| 13183-79-4 | 5-Mercapto-1-Methyltetrazole | 864731-61-3 | Fluralaner | 68373-14-8 | Sulbactam acid |
| 173334-57-1 | Aliskiren | 54-31-9 | Furosemide | 76497-13-7 | Sultamicillin |
| 73547-70-3 | Ceftazidime dihydrochloride | 1369764-02-2 | Lemborexant | 89786-04-9 | Tazobactam acid |
| 113136-77-9 | Cyclanilide | 1138245-21-2 | Mirogabalin besylate | 2023788-19-2 | Tirzepatide |
| 211427-08-6 | Diquafosol tetrasodium | 186826-86-8 | Moxifloxacin hydrochloride | 1197-18-8 | Tranexamic acid |
| 1229194-11-9 | Edoxaban | 1192491-61-4 | NXL 104 | 2050057-56-0 | Upadacitinib |
| 1210344-83-4 | Ertugliflozin L-pyroglutamic acid | 144689-63-4 | Olmesartan Medoxomil | 1190389-15-1 | Vibegron |
| 1632006-28-0 | Esaxerenone | 93-10-7 | Quinaldic acid | 7078-98-0 |
2,6-bis(1,1-dimethylethyl)-4- (phenylmethylene)-2, 5-cyclohexadien-1-one |
| Biocatalysis | |||||
Tranexamic Acid (CAS 1197-18-8) is a high-purity, GMP-compliant antifibrinolytic API. It inhibits plasminogen activation to control excessive bleeding, widely used for surgical hemostasis, menorrhagia, and hemorrhagic disorders. It meets USP, EP and ICH pharmacopoeial standards and is suitable for oral, injectable and topical pharmaceutical formulations.
Upadacitinib (CAS 2050057-56-0) is a high-purity, GMP-compliant API, a potent and selective JAK1 inhibitor (ABT-494). It treats rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and other autoimmune diseases. Meeting USP, EP and ICH standards, it's ideal for oral extended-release tablet formulation development and commercial production
Vibegron (CAS 1190389-15-1) is a high-purity, GMP-compliant selective β3-adrenoceptor agonist API. It is clinically used for overactive bladder (OAB) to relieve urinary urgency, frequency and urge incontinence, with good cardiovascular safety profile. It conforms to USP, EP and ICH quality standards, suitable for oral pharmaceutical formulation R&D and commercial manufacturing.
Our hours
Monday to Friday
(8:30-17:30)